ERBA Diagnostics, Inc. announced that it has received clearance from the U.S. Food and Drug Administration (FDA) on the 510(k) premarket submission that ERBA Diagnostics had filed for its new clinical chemistry analyzer -- the XL 200. The XL-200 is a random access, clinical chemistry analyzer that can perform up to 400 tests per hour. Clinical chemistry analysis is one of the most widely and routinely performed diagnostics procedures in all clinical diagnostics laboratories.